Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of...
Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of ... should be considered when selecting gastric cancer patients for preoperative therapy. ... Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of ... Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect... ...http://jgo.amegroups.com/article/view/13645
Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a...
... of gastric cancer patients after surgery according to the UICC stage classification and the general rules for gastric cancer ... Gastric CancerGastric Cancer PatientPerineural InvasionLymphatic Vessel InvasionAdjuvant Chemoradiotherapy ... Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a ... blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients. Br J Cancer ...http://ro-journal.biomedcentral.com.preview-live.oscarjournals.springer.com/articles/10.1186/1748-717X-7-169
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population...
47 specialist out-patient clinics and 73 general out-patient clinics. All essential clinical information including patients' ... thus minimising the selection, information and recall biases. As all medications are dispensed by the hospital pharmacy at a ... As there may be a delay in the diagnosis of gastric cancer, patients who developed gastric cancer within the first year of H. ... Since gastric cancer can masquerade as non-healing ulcer, all patients with gastric ulcer diagnosed at the time of or any time ...http://gut.bmj.com/content/67/1/28
Her 2 Testing in Indian Patients With Gastric Cancer
Gastric cancer remains a major health issue and a leading cause of cancer death worldwide, although the prevalence and ... The patient will be. de-identified.. 4. Selection of Study Population. Inclusion Criteria:. 100 consecutive patients with ... Test for Her 2 in 100 consecutive gastric cancer patients Immuno-histochemistry will be. done in all patients. Patients with 2 ... Patients will have the Her2 tested in 100 consecutive gastric cancer samples by. immunohistochemistry and patients with 2+ and ...http://www.knowcancer.com/cancer-trials/NCT01814345/
A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients - Full Text View -...
Gastric cancer is a heterogeneous disease with differing chemosensitivities to anti-cancer drugs. Current selection of standard ... Evaluated treatment response of standard-of-care chemotherapy in an enriched patient groups defined as 'responder' based on ... Gastric cancer is the world's second leading cause of cancer death. For patients with unresectable disease or recurrent disease ... The key challenge in managing patients with advanced gastric cancer is to identify the appropriate drugs for patients who might ...https://clinicaltrials.gov/ct2/show/NCT01100801?recr=Open&cond=%22Stomach+Diseases%22&rank=11
Vol 8, No 6 (December 2017) - Journal of Gastrointestinal Oncology
... prevention and clinical investigations of gastrointestinal cancer treatment. ... Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of ... Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer Joseph Chao, James Lin, Paul ... Heated intraperitoneal chemotherapy and gastrectomy for gastric cancer in the U.S.: the time is now Zachary J. Brown, Jonathan ...http://jgo.amegroups.com/issue/current/showToc
Most recent papers with the keyword Novel Addiction Treatment | Read by QxMD
PURPOSE: Refining the selection of HER2 positive metastatic gastric cancer patients candidates for trastuzumab is a challenge ... The development of medications to treat cocaine use disorders has thus far defied success, leaving this patient population ... Biomarkers of primary resistance to trastuzumab in HER2-positive metastatic gastric cancer patients: the AMNESIA case-control ... read/29208673/biomarkers-of-primary-resistance-to-trastuzumab-in-her2-positive-metastatic-gastric-cancer-patients-the-amnesia- ...https://www.readbyqxmd.com/keyword/73745
Highlights of This Issue | Clinical Cancer Research
Optimal Patient Selection for Trastuzumab Treatment in AGC. Ock et al. Page 2520. In HER2 (+) gastric cancer (GC), although ... no biomarker for patient selection has been identified. To define the optimal patients who benefit from trastuzumab, Ock and ... These findings are helpful for optimal patient selection for trastuzumab in HER2(+) GC. ... In all HER2 (+) GC, patients with HER2/CEP17 ratio ≥ 4.48 showed the better OS. Especially, in patients with HER2 IHC ≤ 2+, ...http://clincancerres.aacrjournals.org/content/21/11/2413
Comparison of prognostic nomograms based on different nodal staging systems in patients with resected gastric cancer
Patient characteristics for the multiple imputed datasets are listed in Table S2. The median numbers of MLNs and THNs were 1 ( ... Table 2 shows the MLN-, LNR-, and LODDS-based final Cox models obtained by stepwise backward selection (P , 0.050). The hazard ... The impact of total retrieved lymph nodes on staging and survival of patients with pT3 gastric cancer. Cancer. 2007;110:745-51 ... Gastric Cancer. 2014;17:287-93 19. Lai JF, Kim S, Kim K. et al. Prediction of recurrence of early gastric cancer after curative ...http://jcancer.org/v08p0950.htm
Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer |...
active chemotherapy comparator rather than placebo in this hard-to-treat patient. population - Safety profile was consistent ... Please go to http://www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.. About ... About Gastric/Gastroesophageal Junction Cancer Globally, gastric cancer is the fifth most common cancer but the third most ... Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer. ...https://www.perssupport.nl/persbericht/281117117/merck-and-pfizer-provide-update-on-phase-iii-javelin-gastric-300-study-in-patients-with-pre-treated-advanced-gastric-cancer
Abstract 3988: MicroRNA expression associated with response grade in gastric cancer patients' tumors | Cancer Research
... of drug resistance that should manage to determine a predictable miRNA signature to perform a correct patient selection for GC ... Abstract 3988: MicroRNA expression associated with response grade in gastric cancer patients' tumors. Michelle Maccarini ... MicroRNA expression associated with response grade in gastric cancer patients' tumors. [abstract]. In: Proceedings of the 106th ... Abstract 3988: MicroRNA expression associated with response grade in gastric cancer patients' tumors ...http://cancerres.aacrjournals.org/content/75/15_Supplement/3988
Dual Functions of Natural Killer Cells in Selection and Differentiation of Stem Cells; Role in Regulation of Inflammation and...
Impaired IFN-gamma production after stimulation with bacterial components by natural killer cells from gastric cancer patients ... The inability of patient NK cells to contain cancer stem cells potentially due to the flooding of NK cells by proliferating ... NK cell cytotoxic function were also seen in several cancer patients including those of the oral and ovarian cancer patients [ ... Tumor lymphocytes in patients with advanced ovarian cancer: changes during in vitro culture and implications for immunotherapy ...http://www.jcancer.org/v04p0012.htm
Long-term Trends in Primary Sites of Gastric Adenocarcinoma in Japan and the United States
Cohort Selection. Data for Japanese patients were identified from the Gastric Cancer Database at the Cancer Institute Hospital ... patient data for 78,625 incident cases of gastric cancer from 1973 - 2012 were obtained from the National Cancer Institute's ... Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. ... Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. ...http://www.jcancer.org/v08p1935.htm
Stomach (Gastric) Cancer Screening (PDQ®)-Health Professional Version - National Cancer Institute
Review the evidence on the benefits and harms of screening for gastric cancer using barium-meal photofluorography, gastric ... gastric) cancer, there is no standard or routine screening test for the general U.S. population. ... Go to Patient Version Note: Separate PDQ summaries on Stomach (Gastric) Cancer Prevention, Gastric Cancer Treatment, and Levels ... gastric) cancer screening. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does ...https://www.cancer.gov/types/stomach/hp/stomach-screening-pdq
The role of surgery in patients with advanced gastric cancer. - Oxford Clinical Trials Research Unit
Patient selection is critical to achieving satisfactory outcomes, and involves careful assessment of both patient fitness and ... There is evidence of nutritional and quality of life benefit in the first 2 years after surgery from formation of a gastric ... Only a minority of patients progress to potentially curative surgery after staging and fitness assessment in Western centres. ... and those of peri-operative death much less for an individual patient accepted for surgery in 2006 than they would have been in ...https://www.octru.ox.ac.uk/publications/195243
Herceptin (Trastuzumab): Side Effects, Interactions, Warning, Dosage & Uses
Figure 7 : Updated Overall Survival in Patients with Metastatic Gastric Cancer (Study 7). ... Patient Selection. Select patients based on HER2 protein overexpression or HER2 gene amplification in tumor specimens [see ... gastric cancer should be performed using FDA-approved tests specifically for gastric cancers due to differences in gastric vs. ... 222 patients). Both trials studied patients with metastatic breast cancer whose tumors overexpress the HER2 protein. Patients ...https://www.rxlist.com/herceptin-drug.htm
Laparoscopic Versus Open Subtotal Gastrectomy for Adenocarcinoma: A Case-Control Study | SpringerLink
... is to compare technical feasibility and oncologic efficacy of totally laparoscopic versus open subtotal gastrectomy for gastric ... Selection of patients with gastric adenocarcinoma for laparoscopic staging. Am J Surg. 2006;191(1):134-8.PubMedCrossRefGoogle ... Gastric cancer: the dispute between East and West. Gastric Cancer. 2005;8(2):59-61.PubMedCrossRefGoogle Scholar ... Patient demographics, tumor-node-metastasis (TNM) stage, histologic features, location of tumor, lymph node retrieval, ...https://link.springer.com/article/10.1245/s10434-009-0386-8
Herceptin Dosage Guide - Drugs.com
Patient Selection. Select patients based on HER2 protein overexpression or HER2 gene amplification in tumor specimens [see ... gastric cancer should be performed using FDA-approved tests specifically for gastric cancers due to differences in gastric vs. ... Metastatic Gastric Cancer. *Administer Herceptin at an initial dose of 8 mg/kg as a 90-minute intravenous infusion followed by ... Breast Cancer, Adjuvant tamoxifen, letrozole, Femara, Taxol, paclitaxel, trastuzumab, More.... Breast Cancer, Metastatic ...https://www.drugs.com/dosage/herceptin.html
Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications
... gastric, or esophageal cancer patients [65, 74-76]. Finally, some SNPs relating to miRNA function can potentially influence the ... and demonstrate the presence of negative selection against sequence variations. However, in lung cancer, SNPs have been ... the only lncRNA with prognostic significance in lung cancer and is associated with high metastatic potential and poor patient ... "Reduced expression of Dicer associated with poor prognosis in lung cancer patients," Cancer Science, vol. 96, no. 2, pp. 111- ...https://www.hindawi.com/journals/gri/2012/737416/
Delays in diagnosing oesophagogastric cancer | The BMJ
... presumably a selection of healthy people) have stomach screening annually. The suggestion that "patients with new onset ... cancer. The low case fatality from gastric cancer in Japan is a logical consequence of such biases, given that over six million ... Editor-The finding that gastric cancer detected early has a long doubling time (several years) whereas that diagnosed in an ... necropsy studies indicate that prostate cancer is present in nearly half of older men, suggesting that many occult cancers ...http://www.bmj.com/content/315/7105/426.3
A Population-based Study on Lymph Node Retrieval in Patients with Esophageal Cancer: Results from the Dutch Upper...
Background For esophageal cancer, the number of retrieved lymph nodes (LNs) is often used as a quality indicator. The aim of ... Patient Selection. All patients undergoing surgery for esophageal cancer with curative intention between 2011 and 2016 were ... The influence of a composite hospital volume of upper gastrointestinal cancer resections on outcomes of gastric cancer surgery ... All patients with esophageal or gastric cancer with intent of resection should be registered. Results on quality indicators are ...https://rd.springer.com/article/10.1245/s10434-018-6396-7
Ultrasound for determining the spread of stomach cancer | Cochrane
We collected the data on 7747 patients with gastric cancer who were staged with EUS. Overall the quality of the included ... Selection criteria: We included studies that met the following main inclusion criteria: 1) a minimum sample size of 10 patients ... combination with other staging instruments may increase our ability to correctly stage the disease and thus optimize patient ... There is much debate on the diagnostic performance of endoscopic ultrasound (EUS) in the preoperative staging of gastric cancer ...http://www.cochrane.org/CD009944/UPPERGI_ultrasound-for-determining-the-spread-of-stomach-cancer
Patient Selection And Technique - Pancreatic Cancer
Selection of patients and the technique utilized for laparoscopy in the assessment of patients with ascites and potential ... is the appearance of tuberculous peritonitis which may mimic small implants seen frequently in pancreatic or gastric cancer.14 ... Patient Selection And Technique. Last Updated on Tue, 12 Apr 2016 , Pancreatic Cancer ... In selecting patients for laparoscopy, it is important to consider the overall plan for the patient with malignant disease ...https://www.barnardhealth.us/pancreatic-cancer/patient-selection-and-technique.html
Theodor Billroth - Wikipedia
But his most famous accomplishment is unquestionably the first successful gastrectomy for gastric cancer. On January 29, 1881, ... with resultant improvements in patient selection. He was appointed professor of surgery at the University of Vienna in 1867, in ... He did not limit himself to surgery only, and conducted extensive research on an ailment that affected many surgery patients at ... He was the first surgeon to excise a rectal cancer and by 1876, he had performed 33 such operations. By 1881, Billroth had made ...https://en.wikipedia.org/wiki/Theodor_Billroth
Somatic evolution in cancer - Wikipedia
... gastric cancer, bile duct cancer, pancreatic cancer, small intestine cancer and colon cancer. In the colon, a field defect ... Clonal expansion is the signature of natural selection in cancer. Cancer therapies act as a form of artificial selection, ... November 1999). "Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer". J. Natl. Cancer Inst ... "The mutation spectrum revealed by paired genome sequences from a lung cancer patient". Nature. 465 (7297): 473-7. doi:10.1038/ ...https://en.wikipedia.org/wiki/Somatic_evolution_in_cancer
Download our free solidary book to support research on VHL disease